2,778 results
·
28ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: FDA Class 3
×
Device, Angioplasty, Laser, Coronary
FDA Pre-Market Approval
FDA Class 3
·CVX-300 and CVX-300-P EXCIMER LASER SYSTEM
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·PD-L1 IHC 22C3 pharmDX
Device, Angioplasty, Laser, Coronary
FDA Pre-Market Approval
FDA Class 3
·ELCA CORONARY LASER ATHERECTOMY CATHETERS
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·PD-L1 IHC 28-8 PHARMDX (Non-Squamous Indication)
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·PD-L1 IHC 28-8 pharmDx
Device, Angioplasty, Laser, Coronary
FDA Pre-Market Approval
FDA Class 3
·ANGIOPLASTY/LASER/CORONARY DEVICE
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·VENTANA PD-LI (SP263) Assay
Device, Angioplasty, Laser, Coronary
FDA Pre-Market Approval
FDA Class 3
·Philips Laser System
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·PD-L1 IHC 28-8 pharmDx
Device, Angioplasty, Laser, Coronary
FDA Pre-Market Approval
FDA Class 3
·CVX-300 Excimer Laser System and ELCA Coronary Atherectomy Catheters
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·PD-L1 IHC 28-8 pharmDx
Device, Angioplasty, Laser, Coronary
FDA Pre-Market Approval
FDA Class 3
·SPECTRANECTICS CVX-300 EXCIMER LASER SYSTEM
Device, Angioplasty, Laser, Coronary
FDA Pre-Market Approval
FDA Class 3
·MODEL 1210 OMNIPULSE(TM) HOLMIUM LASER SYSTEM
Device, Angioplasty, Laser, Coronary
FDA Pre-Market Approval
FDA Class 3
·ELCA Coronary Laser Catheters
Device, Angioplasty, Laser, Coronary
FDA Pre-Market Approval
FDA Class 3
·ELCA Catheters
Device, Angioplasty, Laser, Coronary
FDA Pre-Market Approval
FDA Class 3
·SPECTRANETICS ELCA LASER CATHETERS
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·PD-L1 IHC 22C3 pharmDx
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·PD-L1 IHC 22C3 pharmDx
Device, Angioplasty, Laser, Coronary
FDA Pre-Market Approval
FDA Class 3
·EXCIMER LASER CORONARY ATHERECTOMY CATHETER
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·PD-L1 IHC 28-8 pharmDx